A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Public ClinicalTrials.gov record NCT06671496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The participants will be treated with either zasocitinib, or placebo. Participants will be in the study for up to 60 weeks.
Study identification
- NCT ID
- NCT06671496
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 601 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 10, 2025 (Actual)
- Primary completion
- May 18, 2027 (Estimated)
- Completion
- Jan 26, 2028 (Estimated)
- Last update posted
- Oct 14, 2026
2025 – 2028
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Mesa | Arizona | 85210 | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Phoenix | Arizona | 85032 | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Tucson | Arizona | 85748 | — |
| Biovin Enterprises LLC dba Medvin Clinical Research | Covina, CA | Covina | California | 91722 | — |
| RASF- Clinical Research Center | Boca Raton | Florida | 33486-1390 | — |
| Direct Helpers Medical Center | Hialeah | Florida | 33012 | — |
| IRIS Research and Development | Plantation, FL | Plantation | Florida | 33324 | — |
| BayCare Medical Group | St. Petersburg | Florida | 33705 | — |
| North Georgia Rheumatology Group PC | Lawrenceville | Georgia | 30046 | — |
| Clinic of Robert Hozman | Skokie | Illinois | 60076 | — |
| Graves Gilbert Clinic | Bowling Green | Kentucky | 42101 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21205 | — |
| Advanced Rheumatology PC | Lansing, MI | Lansing | Michigan | 48910-5894 | — |
| AARR- Kansas City Physician Partners | Kansas City | Missouri | 85032 | — |
| DJL Clinical Research | Charlotte, NC | Charlotte | North Carolina | 28210 | — |
| University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division | Cleveland | Ohio | 44106 | — |
| Paramount Medical Research & Consulting, LLC | Middleburg Heights | Ohio | 44130 | — |
| Altoona Center for Clinical Research | Ducansville, PA | Duncansville | Pennsylvania | 16635 | — |
| AARR- Lone Star Arthritis & Rheumatology Associates | Fort Worth | Texas | 76109 | — |
| Biopharma Informatic | Hassan | Houston | Texas | 77089 | — |
| Advanced Rheumatology of Houston - The Woodlands | The Woodlands | Texas | 77382 | — |
| Swedish Rheumatology Research | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06671496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06671496 live on ClinicalTrials.gov.